Published in Nucleic Acids Res on March 17, 2017
ETV4 and AP1 transcription factors form multivalent interactions with three sites on the MED25 activator-interacting domain. J Mol Biol (2017) 0.75
Flipping states: a few key residues decide the winning conformation of the only universally conserved transcription factor. Nucleic Acids Res (2017) 0.75
PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr (2010) 108.52
Phaser crystallographic software. J Appl Crystallogr (2007) 108.34
NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR (1995) 93.94
Features and development of Coot. Acta Crystallogr D Biol Crystallogr (2010) 89.46
MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr (2009) 53.36
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science (2005) 39.06
Protein production by auto-induction in high density shaking cultures. Protein Expr Purif (2005) 29.74
Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol (1997) 11.14
Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature (2007) 10.94
Primary structure effects on peptide group hydrogen exchange. Proteins (1993) 10.79
A census of human transcription factors: function, expression and evolution. Nat Rev Genet (2009) 9.19
Coupling of folding and binding for unstructured proteins. Curr Opin Struct Biol (2002) 6.53
Using circular dichroism spectra to estimate protein secondary structure. Nat Protoc (2006) 5.81
TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer. Cancer Res (2006) 4.99
Autoinhibition and activation mechanisms of the Wiskott-Aldrich syndrome protein. Nature (2000) 4.51
Genetically encoding N(epsilon)-acetyllysine in recombinant proteins. Nat Chem Biol (2008) 3.68
Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer. Cancer Res (2008) 3.59
Genome-wide analyses reveal properties of redundant and specific promoter occupancy within the ETS gene family. Genes Dev (2007) 3.56
Genomic and biochemical insights into the specificity of ETS transcription factors. Annu Rev Biochem (2011) 2.89
Intrinsically disordered proteins in cellular signalling and regulation. Nat Rev Mol Cell Biol (2015) 2.69
Variable control of Ets-1 DNA binding by multiple phosphates in an unstructured region. Science (2005) 2.47
Autoinhibitory domains: modular effectors of cellular regulation. Annu Rev Cell Dev Biol (2002) 2.44
ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss. Nat Med (2013) 2.26
New androgen receptor genomic targets show an interaction with the ETS1 transcription factor. EMBO Rep (2007) 2.17
Accurate quantitation of water-amide proton exchange rates using the phase-modulated CLEAN chemical EXchange (CLEANEX-PM) approach with a Fast-HSQC (FHSQC) detection scheme. J Biomol NMR (1998) 2.14
Multiple independent binding sites for small-molecule inhibitors on the oncoprotein c-Myc. J Am Chem Soc (2009) 1.92
Determination of secondary structure populations in disordered states of proteins using nuclear magnetic resonance chemical shifts. Biochemistry (2012) 1.87
ETV1 directs androgen metabolism and confers aggressive prostate cancer in targeted mice and patients. Genes Dev (2013) 1.87
Characterization of the cooperative function of inhibitory sequences in Ets-1. Mol Cell Biol (1996) 1.85
Modulation of transcription factor Ets-1 DNA binding: DNA-induced unfolding of an alpha helix. Science (1995) 1.71
Structure of Cdc42 bound to the GTPase binding domain of PAK. Nat Struct Biol (2000) 1.65
Structure and intrinsic disorder in protein autoinhibition. Structure (2013) 1.64
SLIC: a method for sequence- and ligation-independent cloning. Methods Mol Biol (2012) 1.64
Auto-inhibition of Ets-1 is counteracted by DNA binding cooperativity with core-binding factor alpha2. Mol Cell Biol (2000) 1.62
The structural and dynamic basis of Ets-1 DNA binding autoinhibition. J Biol Chem (2004) 1.62
Steric mechanism of auto-inhibitory regulation of specific and non-specific DNA binding by the ETS transcriptional repressor ETV6. J Mol Biol (2013) 1.58
Oncogenic ETS proteins mimic activated RAS/MAPK signaling in prostate cells. Genes Dev (2011) 1.56
p300 in prostate cancer proliferation and progression. Cancer Res (2003) 1.50
Targeting the disordered C terminus of PTP1B with an allosteric inhibitor. Nat Chem Biol (2014) 1.40
Induction of prostatic intraepithelial neoplasia and modulation of androgen receptor by ETS variant 1/ETS-related protein 81. Cancer Res (2009) 1.39
The protein non-folding problem: amino acid determinants of intrinsic order and disorder. Pac Symp Biocomput (2001) 1.29
Acetylation-mediated transcriptional activation of the ETS protein ER81 by p300, P/CAF, and HER2/Neu. Mol Cell Biol (2003) 1.27
ETV4 promotes metastasis in response to activation of PI3-kinase and Ras signaling in a mouse model of advanced prostate cancer. Proc Natl Acad Sci U S A (2013) 1.26
Structural analysis of the autoinhibition of Ets-1 and its role in protein partnerships. J Biol Chem (2002) 1.25
p300 (histone acetyltransferase) biomarker predicts prostate cancer biochemical recurrence and correlates with changes in epithelia nuclear size and shape. Prostate (2008) 1.19
Fuzziness: linking regulation to protein dynamics. Mol Biosyst (2011) 1.18
Regulation of the ETS transcription factor ER81 by the 90-kDa ribosomal S6 kinase 1 and protein kinase A. J Biol Chem (2002) 1.14
DNA binding by the ETS protein TEL (ETV6) is regulated by autoinhibition and self-association. J Biol Chem (2010) 1.13
The PEA3 Ets transcription factor comprises multiple domains that regulate transactivation and DNA binding. J Biol Chem (2000) 1.12
DNA binding by the ETS-domain transcription factor PEA3 is regulated by intramolecular and intermolecular protein.protein interactions. J Biol Chem (2001) 1.10
The affinity of Ets-1 for DNA is modulated by phosphorylation through transient interactions of an unstructured region. J Mol Biol (2008) 1.10
Structural and dynamic studies of the transcription factor ERG reveal DNA binding is allosterically autoinhibited. Proc Natl Acad Sci U S A (2013) 1.02
Solution structure of the two RNA recognition motifs of hnRNP A1 using segmental isotope labeling: how the relative orientation between RRMs influences the nucleic acid binding topology. J Biomol NMR (2012) 0.97
A small molecule that binds and inhibits the ETV1 transcription factor oncoprotein. Mol Cancer Ther (2014) 0.94
Autoinhibition of ETV6 (TEL) DNA binding: appended helices sterically block the ETS domain. J Mol Biol (2012) 0.93
Two functionally distinct domains responsible for transactivation by the Ets family member ERM. Oncogene (1996) 0.90
Cellular and molecular insights into Hox protein action. Development (2015) 0.90
CSI 2.0: a significantly improved version of the Chemical Shift Index. J Biomol NMR (2014) 0.87
Synergy of aromatic residues and phosphoserines within the intrinsically disordered DNA-binding inhibitory elements of the Ets-1 transcription factor. Proc Natl Acad Sci U S A (2014) 0.84
Structures of the Ets Protein DNA-binding Domains of Transcription Factors Etv1, Etv4, Etv5, and Fev: DETERMINANTS OF DNA BINDING AND REDOX REGULATION BY DISULFIDE BOND FORMATION. J Biol Chem (2015) 0.83
A positive role of DBC1 in PEA3-mediated progression of estrogen receptor-negative breast cancer. Oncogene (2014) 0.83
Chemical perturbation of an intrinsically disordered region of TFIID distinguishes two modes of transcription initiation. Elife (2015) 0.83
Dynamic modification of the ETS transcription factor PEA3 by sumoylation and p300-mediated acetylation. Nucleic Acids Res (2011) 0.83
Efficient segmental isotope labeling of multi-domain proteins using Sortase A. J Biomol NMR (2015) 0.82
Binding cavities and druggability of intrinsically disordered proteins. Protein Sci (2015) 0.80
A novel allosteric mechanism on protein-DNA interactions underlying the phosphorylation-dependent regulation of Ets1 target gene expressions. J Mol Biol (2014) 0.78
Conformational Dynamics and the Binding of Specific and Nonspecific DNA by the Autoinhibited Transcription Factor Ets-1. Biochemistry (2016) 0.77
Structural basis of Ets1 activation by Runx1. Leukemia (2014) 0.77
FACT Disrupts Nucleosome Structure by Binding H2A-H2B with Conserved Peptide Motifs. Mol Cell (2015) 1.00